News summary

Obesity and COVID-19 severity independently shape adipokine dysregulation and immune cell remodeling

Source: Frontiers - Health • Published: 08 Sept 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

This article previews research dissecting how obesity and COVID-19 severity separately reshape adipokine signaling and immune cell landscapes. Expect a mechanistic, immunology-focused study exploring distinct patterns tied to metabolic status and illness stage.

Obesity and COVID-19 severity independently shape adipokine dysregulation and immune cell remodeling
Key Takeaways
  • Obesity independently raised TNF-α and resistin levels, with resistin also increasing with disease severity.
  • Disease severity independently elevated IL-1β, IL-8, and NETs-ISG15 complexes with IL-8 and NETs-ISG15 amplified in obese critical patients.
  • Critical illness caused symmetric CD8 Treg depletion and LDG expansion irrespective of obesity, while Th17 cells were suppressed by both obesity and severity.
Read the full article at Frontiers - Health

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?